NCT00535418View on ClinicalTrials.gov

Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

July 31, 2002

Conditions
Breast Cancer
Interventions
DRUG

Letrozole

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY